For women with early-stage estrogen-receptor positive breast cancer, adjuvant endocrine therapy is known to decrease the likelihood of recurrence and improve survival, while omitting the therapy […]

Five commonly prescribed drugs may be associated with a lower risk for aneurysmal subarachnoid hemorrhage (aSAH), a drug-wide association study suggested. The blood pressure drug lisinopril; […]

TOPLINE:  Having more tender than swollen joints is linked to worse patient-reported outcomes (PROs), particularly in pain interference, social participation, and fatigue, in patients with rheumatoid […]

BOSTON — Nearly 1 in 5 breast cancer survivors will gain more than 10% of their bodyweight in the 6 years following their diagnosis, according to […]

HOUSTON — A hospital stay often means poor sleep, but empowering hospitalized patients to take action can lead to better sleep, new research suggested. Results from […]

In the common challenge of patients with relapsed multiple myeloma who are refractory to lenalidomide after receiving frontline treatment with the drug, treatment with the first-in-class, […]

In just 4 years, there’s been a significant evolution in the profile of pediatric and young adult patients who’ve taken the chimeric antigen receptor (CAR) T-cell […]

A new antibiotic uses a never-before-seen mechanism to deliver a direct hit on tough-to-treat infections while leaving beneficial microbes alone. The strategy could lead to a […]

LONG BEACH, California — A catheter-directed mechanical pulmonary embolism (PE) extraction system approved on April 4 by the US Food and Drug Administration (FDA) demonstrated an […]